BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4426109)

  • 41. Dietary fatty acid-induced alterations of hepatic microsomal drug metabolism.
    Norred WP; Wade AE
    Biochem Pharmacol; 1972 Nov; 21(21):2887-97. PubMed ID: 4646808
    [No Abstract]   [Full Text] [Related]  

  • 42. Characterization of cytochrome P-450-dependent aminopyrine N-demethylase in rat brain: comparison with hepatic aminopyrine N-demethylation.
    Marietta MP; Vesell ES; Hartman RD; Weisz J; Dvorchik BH
    J Pharmacol Exp Ther; 1979 Feb; 208(2):271-9. PubMed ID: 33263
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on drug metabolism. 13. Possible role of liver microsomal cytochrome P-450 in the oxidative N-demethylation of p-substituted dimethylaniline, N-methyl-N-alkylaniline and N-methyl-N-acylaniline derivatives.
    Kitagawa H; Kitada M; Horie T
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):650-6. PubMed ID: 5045610
    [No Abstract]   [Full Text] [Related]  

  • 44. Radical production in amine oxidation by liver microsomes.
    Stier A; Reitz I
    Xenobiotica; 1971; 1(4):499-500. PubMed ID: 4153032
    [No Abstract]   [Full Text] [Related]  

  • 45. Substrate interaction with hydroxylase system in liver microsomes.
    Imai Y; Sato R
    Biochem Biophys Res Commun; 1966 Mar; 22(6):620-6. PubMed ID: 4380276
    [No Abstract]   [Full Text] [Related]  

  • 46. Cytochrome P-450 purified to apparent homogeneity from phenobarbital-induced rabbit liver microsomes: catalytic activity and other properties.
    van der Hoeven TA; Haugen DA; Coon MJ
    Biochem Biophys Res Commun; 1974 Sep; 60(2):569-75. PubMed ID: 4418358
    [No Abstract]   [Full Text] [Related]  

  • 47. Spectral and catalytic properties of cytochrome P-450 from four wild bird species.
    Yawetz A; Agosin M; Perry AS
    Comp Biochem Physiol C Comp Pharmacol; 1978; 59(1):45-9. PubMed ID: 24521
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of highly-purified microsomal cytochromes P-450 and NADPH-cytochrome P-450 reductases by peptide mapping.
    Guengerich FP
    Biochem Biophys Res Commun; 1978 Jun; 82(3):820-7. PubMed ID: 697774
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates.
    Gigon PL; Gram TE; Gillette JR
    Mol Pharmacol; 1969 Mar; 5(2):109-22. PubMed ID: 4389181
    [No Abstract]   [Full Text] [Related]  

  • 50. Monooxygenase drug metabolizing activity in CaCl 2 -aggregated hepatic microsomes from rat liver.
    Kupfer D; Levin E
    Biochem Biophys Res Commun; 1972 May; 47(3):611-8. PubMed ID: 4402636
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of suramin (Bayer 205) on hepatic microsomal cytochromes P-450, b 5 , and demethylation activity in rats.
    Basu TK; Stewart PS; Harris RG; Williams DC
    Biochem Pharmacol; 1973 Apr; 22(8):987-9. PubMed ID: 4693831
    [No Abstract]   [Full Text] [Related]  

  • 52. New potent modifiers of liver microsomal drug metabolism: 1-arylimidazoles.
    Leibman KC; Ortiz E
    Drug Metab Dispos; 1973; 1(6):775-9. PubMed ID: 4156300
    [No Abstract]   [Full Text] [Related]  

  • 53. Inability of substrates to alter the carbon monoxide and ethyl isocyanide difference spectra of microsomal hemoprotein.
    Alvares AP; Schilling G; Levin W; Kuntzman R
    J Pharmacol Exp Ther; 1971 Jan; 176(1):1-10. PubMed ID: 4398215
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunochemical evidence for the participation of cytochrome b5 in the NADH synergism of the NADPH-dependent mono-oxidase system of hepatic microsomes.
    Mannering GJ; Kuwahara S; Omura T
    Biochem Biophys Res Commun; 1974 Mar; 57(2):476-81. PubMed ID: 4151403
    [No Abstract]   [Full Text] [Related]  

  • 55. Response of hepatic microsomal mixed-function oxidases to various types of insecticide chemical synergists administered to mice.
    Skrinjarić-Spoljar M; Matthews HB; Engel JL; Casida JE
    Biochem Pharmacol; 1971 Jul; 20(7):1607-18. PubMed ID: 5163091
    [No Abstract]   [Full Text] [Related]  

  • 56. Cytochrome P-450 associated with free hepatic polyribosomes.
    Ichikawa Y; Mason HS
    Drug Metab Dispos; 1973; 1(1):62-5. PubMed ID: 4149421
    [No Abstract]   [Full Text] [Related]  

  • 57. Evidence for a predominantly NADH-dependent O-dealkylating system in rat hepatic microsomes.
    Kuwahara S; Mannering GJ
    Biochem Pharmacol; 1985 Dec; 34(24):4215-28. PubMed ID: 3935115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Post mortem characteristics of the hepatic microsomal drug oxidising enzyme system.
    Macleod SM; Renton KW; Eade NR
    Chem Biol Interact; 1973 Jul; 7(1):29-37. PubMed ID: 4352876
    [No Abstract]   [Full Text] [Related]  

  • 59. Sex-dependent effects of cyclic AMP on the hepatic mixed function oxidase system.
    Ross WE; Simrell C; Oppelt WW
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):319-32. PubMed ID: 4349298
    [No Abstract]   [Full Text] [Related]  

  • 60. Spectral and catalytic properties of cytochrome P-450 from a diazinon-resistant housefly strain.
    Capdevila J; Perry AS; Agosin M
    Chem Biol Interact; 1974 Aug; 9(2):105-16. PubMed ID: 4371680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.